Monitor Tevogen's quarterly revenue trajectory relative to the $1.0 billion threshold; the shares are unlikely to vest in the near term given the company's current revenue base. No immediate trading catalyst.
Price Chart
Executive Summary
Tevogen granted its CEO and CFO performance-based restricted stock awards totaling 8.75 million shares, vesting only if the company achieves $1.0 billion in aggregate revenue by September 30, 2031. This is a routine compensatory arrangement with an extremely high bar for vesting, and no financial results or guidance were provided. The filing has no immediate material impact on the stock.
Key Facts
- CEO Ryan Saadi received 8,000,000 restricted shares; CFO Kirti Desai received 750,000 restricted shares.
- Vesting requires Board certification of $1.0 billion in aggregate revenue by September 30, 2031.
- As of the grant, Dr. Saadi owned 74.4% and Mr. Desai owned 6.3% of the 15,736,540 outstanding common shares.
- The restricted shares carry voting rights but cannot be sold or transferred before vesting.
- Unvested shares are forfeited if the revenue threshold is not met, upon termination of service, or upon a change in control without assumption.
Financial Impact
No immediate financial impact; potential dilution of up to 8,750,000 shares (55.6% of current outstanding) if the $1.0 billion revenue threshold is met by 2031.
Risk Factors
- Massive potential dilution (55.6% of current shares outstanding) if the revenue threshold is met.
- CEO's 74.4% ownership concentration creates significant governance risk for minority shareholders.
- The performance condition is extremely ambitious; failure to achieve it results in full forfeiture of the awards.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-042952 |
| Document: form8-k.htm | 0001493152-26-042952 |
| Document: 0001493152-26-042952-index-headers.html | 0001493152-26-042952 |
| Document: 0001493152-26-042952-index.html | 0001493152-26-042952 |
| Document: 0001493152-26-042952.txt | 0001493152-26-042952 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | 8-K | $6.72 | awaiting T+60 | — | $6.40 (−4.76%) |
Sep 16, 2026 5w ago | SC 13D/A | $7.71 | awaiting T+60 | — | $6.40 (−16.99%) |
Sep 16, 2026 5w ago | SC 13D/A | $7.71 | awaiting T+60 | — | $6.40 (−16.99%) |
Sep 16, 2026 5w ago | 8-K | $7.71 | awaiting T+60 | — | $6.40 (−16.99%) |
Jun 26, 2026 17w ago | EFFECT | $7.00 $7.43 | ▼ −6.14% | ▼ −1.66% | $6.40 (+8.57%) |
Jun 12, 2026 19w ago | S-3 | $10.02 $7.34 | ▲ +26.75% | ▲ +27.75% | $6.40 (+36.13%) |
Jun 9, 2026 20w ago | Press Release | $10.75 $7.17 | ▼ −33.30% | ▼ −37.12% | $6.40 (−40.47%) |
May 28, 2026 21w ago | Press Release | $8.04 $6.75 | ▼ −16.04% | ▼ −17.78% | $6.40 (−20.40%) |
May 21, 2026 22w ago | Press Release | $11.57 $6.58 | ▼ −43.10% | ▼ −47.40% | $6.40 (−44.66%) |
Mar 25, 2026 30w ago | Press Release | $5.18 $9.79 | ▲ +88.90% | ▲ +75.44% | $6.40 (+23.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers